Plagues, Pestilences and Diseases
Expect 10 million TB deaths in next five years
Charlotte Plantive
October 14, 2010 - 12:14PM
Ten million people will die of tuberculosis in the next five years if
global funding to fight the disease is not increased, the Stop TB
Partnership warned.
The Partnership, a coalition of governments, non-profits, companies and
international organisations, said 47 billion US dollars (34 billion
euros) are needed to save five million lives between now and 2015,
including two million women and children.
"We need a plan to stop these completely unnecessary deaths," said
Rifat Atun, chair of the Partnership's coordinating board, at the
launch of the coalition's 2011-2015 "Global Plan to Stop TB".
"If we are able to carry out this plan, we will treat 32 million people
and save five million lives," Atun said.
Each year, nine million people contract TB, which hits hardest in the
developing world. Most cases occur in Asia (55 percent) and Africa (30
percent), with India and China alone accounting for 35 percent of all
cases, the Partnership said.
Close to two million people die of the contagious lung infection each
year -- most from treatable cases, it said.
"Tuberculosis is an ancient disease. It should have been eliminated by
today," said Mario Raviglione, director of the World Health
Organisation's Stop TB department.
"The pandemic is slowly declining, but far too slowly."
The Partnership called for renewed efforts to help the most vulnerable
patients -- the more than one million HIV positive people who contract
TB each year and the 400,000 to 500,000 people who develop multi-drug
resistant TB.
Half a million HIV positive people die from TB each year, a quarter of
all AIDS deaths, said Paul de Lay, deputy executive director of UNAids.
"There is a terrible link between HIV and TB," he said.
The coalition said 10 billion US dollars are needed to fund research to
develop a vaccine, new medications and faster and more effective
testing. It said its goal by 2015 is to have three new drug regimens
and four vaccines in Phase III clinical trials, the final step before
drugs go to market.
It said funding to fight the disease has lagged in the past five years,
adding that it needs to make up a funding shortfall of nine billion US
dollars from the last five-year cycle amid limited private-sector
interest in the disease.
"Pharmaceutical companies don't invest enough in TB because it's not a
profitable market," said Christian Lienhardt, senior research advisor
for the Partnership.
"It's a poor people's disease, so TB medication will never be a
blockbuster."
The Partnership said affected countries would not be able to fully fund
the fight against TB, and called on international donors in high-income
countries to kick in 2.8 billion US dollars a year over the next five
years to make up the funding gap.
Tuberculosis is a contagious bacterial infection that spreads by air.
An infected person can spread the disease to about 15 other people per
year.